|
DE3242252A1
(de)
|
1982-11-15 |
1984-05-17 |
Bayer Ag, 5090 Leverkusen |
Heterocyclisch substituierte hydroxyalkyl-azolyl-derivate
|
|
US4631211A
(en)
|
1985-03-25 |
1986-12-23 |
Scripps Clinic & Research Foundation |
Means for sequential solid phase organic synthesis and methods using the same
|
|
ES2008962A6
(es)
|
1987-12-17 |
1989-08-16 |
Marga Investigacion |
Proceso para la preparacion de nuevos compuestos de 2-guanidinotiazol
|
|
JPH01224381A
(ja)
|
1988-03-04 |
1989-09-07 |
Japan Tobacco Inc |
トリコスタチン酸、トリコスタチンａの新規な合成中間体、及びトリコスタチン酸、トリコスタチンａの製造方法。
|
|
EP0347381B1
(de)
|
1988-06-13 |
1992-02-12 |
Ciba-Geigy Ag |
Ungesättigte beta-Ketoesteracetale und ihre Anwendungen
|
|
US5223409A
(en)
|
1988-09-02 |
1993-06-29 |
Protein Engineering Corp. |
Directed evolution of novel binding proteins
|
|
US5096815A
(en)
|
1989-01-06 |
1992-03-17 |
Protein Engineering Corporation |
Generation and selection of novel dna-binding proteins and polypeptides
|
|
US5198346A
(en)
|
1989-01-06 |
1993-03-30 |
Protein Engineering Corp. |
Generation and selection of novel DNA-binding proteins and polypeptides
|
|
US5143854A
(en)
|
1989-06-07 |
1992-09-01 |
Affymax Technologies N.V. |
Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
|
|
EP0502060A4
(en)
|
1989-11-13 |
1993-05-05 |
Affymax Technologies N.V. |
Spatially-addressable immobilization of anti-ligands on surfaces
|
|
US5304121A
(en)
|
1990-12-28 |
1994-04-19 |
Boston Scientific Corporation |
Drug delivery system making use of a hydrogel polymer coating
|
|
US5045538A
(en)
|
1990-06-28 |
1991-09-03 |
The Research Foundation Of State University Of New York |
Inhibition of wasting and protein degradation of mammalian muscle by tetracyclines
|
|
GB9026114D0
(en)
|
1990-11-30 |
1991-01-16 |
Norsk Hydro As |
New compounds
|
|
DE69132531T2
(de)
|
1990-12-06 |
2001-09-13 |
Affymetrix, Inc. (N.D.Ges.D.Staates Delaware) |
Verbindungen und ihre Verwendung in einer binären Synthesestrategie
|
|
EP0501919A1
(de)
|
1991-03-01 |
1992-09-02 |
Ciba-Geigy Ag |
Strahlungsempfindliche Zusammensetzungen auf der Basis von Polyphenolen und Acetalen
|
|
US5225173A
(en)
|
1991-06-12 |
1993-07-06 |
Idaho Research Foundation, Inc. |
Methods and devices for the separation of radioactive rare earth metal isotopes from their alkaline earth metal precursors
|
|
USRE38506E1
(en)
|
1991-10-04 |
2004-04-20 |
Sloan-Kettering Institute For Cancer Research |
Potent inducers of terminal differentiation and methods of use thereof
|
|
US5239113A
(en)
|
1991-10-15 |
1993-08-24 |
Monsanto Company |
Substituted β-amino acid derivatives useful as platelet aggregation inhibitors and intermediates thereof
|
|
DE69233501T2
(de)
|
1991-11-22 |
2006-02-23 |
Affymetrix, Inc. (n.d.Ges.d.Staates Delaware), Santa Clara |
Kombinatorische Strategien für die Polymersynthese
|
|
US5359115A
(en)
|
1992-03-26 |
1994-10-25 |
Affymax Technologies, N.V. |
Methods for the synthesis of phosphonate esters
|
|
US5573905A
(en)
|
1992-03-30 |
1996-11-12 |
The Scripps Research Institute |
Encoded combinatorial chemical libraries
|
|
US5288514A
(en)
|
1992-09-14 |
1994-02-22 |
The Regents Of The University Of California |
Solid phase and combinatorial synthesis of benzodiazepine compounds on a solid support
|
|
ES2204910T3
(es)
|
1992-10-01 |
2004-05-01 |
The Trustees Of Columbia University In The City Of New York |
Bibliotecas quimicas combinatorias complejas codificadas con señales.
|
|
US5480971A
(en)
|
1993-06-17 |
1996-01-02 |
Houghten Pharmaceuticals, Inc. |
Peralkylated oligopeptide mixtures
|
|
US5440016A
(en)
|
1993-06-18 |
1995-08-08 |
Torrey Pines Institute For Molecular Studies |
Peptides of the formula (KFmoc) ZZZ and their uses
|
|
US5886026A
(en)
|
1993-07-19 |
1999-03-23 |
Angiotech Pharmaceuticals Inc. |
Anti-angiogenic compositions and methods of use
|
|
US20030203976A1
(en)
|
1993-07-19 |
2003-10-30 |
William L. Hunter |
Anti-angiogenic compositions and methods of use
|
|
US5362899A
(en)
|
1993-09-09 |
1994-11-08 |
Affymax Technologies, N.V. |
Chiral synthesis of alpha-aminophosponic acids
|
|
US5659016A
(en)
|
1994-09-22 |
1997-08-19 |
Cancer Institute |
RPDL protein and DNA encoding the same
|
|
US6231600B1
(en)
|
1995-02-22 |
2001-05-15 |
Scimed Life Systems, Inc. |
Stents with hybrid coating for medical devices
|
|
US6099562A
(en)
|
1996-06-13 |
2000-08-08 |
Schneider (Usa) Inc. |
Drug coating with topcoat
|
|
US5837313A
(en)
|
1995-04-19 |
1998-11-17 |
Schneider (Usa) Inc |
Drug release stent coating process
|
|
JP3330781B2
(ja)
|
1995-05-22 |
2002-09-30 |
三菱エンジニアリングプラスチックス株式会社 |
ポリカーボネート樹脂組成物
|
|
WO1997011366A1
(en)
|
1995-09-20 |
1997-03-27 |
Merck & Co., Inc. |
Histone deacetylase as target for antiprotozoal agents
|
|
JPH09124918A
(ja)
|
1995-10-30 |
1997-05-13 |
Mitsubishi Eng Plast Kk |
ポリカーボネート樹脂組成物
|
|
US6030945A
(en)
|
1996-01-09 |
2000-02-29 |
Genentech, Inc. |
Apo-2 ligand
|
|
US6777217B1
(en)
|
1996-03-26 |
2004-08-17 |
President And Fellows Of Harvard College |
Histone deacetylases, and uses related thereto
|
|
TW517089B
(en)
|
1996-09-03 |
2003-01-11 |
Res Dev Foundation |
Assessment of intracellular cysteine and glutathione concentrations
|
|
US6068987A
(en)
|
1996-09-20 |
2000-05-30 |
Merck & Co., Inc. |
Histone deacetylase as target for antiprotozoal agents
|
|
WO1998016830A2
(en)
|
1996-10-16 |
1998-04-23 |
The President And Fellows Of Harvard College |
Droplet assay system
|
|
ZA9710342B
(en)
|
1996-11-25 |
1998-06-10 |
Alza Corp |
Directional drug delivery stent and method of use.
|
|
US6273913B1
(en)
|
1997-04-18 |
2001-08-14 |
Cordis Corporation |
Modified stent useful for delivery of drugs along stent strut
|
|
NZ500590A
(en)
|
1997-04-22 |
2001-11-30 |
Cocensys Inc |
Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof
|
|
US6190619B1
(en)
|
1997-06-11 |
2001-02-20 |
Argonaut Technologies, Inc. |
Systems and methods for parallel synthesis of compounds
|
|
US5891507A
(en)
|
1997-07-28 |
1999-04-06 |
Iowa-India Investments Company Limited |
Process for coating a surface of a metallic stent
|
|
US6195612B1
(en)
|
1998-01-05 |
2001-02-27 |
Tama L. Pack-Harris |
Pharmacy benefit management system and method of using same
|
|
US6428960B1
(en)
|
1998-03-04 |
2002-08-06 |
Onyx Pharmaceuticals, Inc. |
Selection method for producing recombinant baculovirus
|
|
US6306866B1
(en)
*
|
1998-03-06 |
2001-10-23 |
American Cyanamid Company |
Use of aryl-substituted pyrimidines as insecticidal and acaricidal agents
|
|
US6153252A
(en)
|
1998-06-30 |
2000-11-28 |
Ethicon, Inc. |
Process for coating stents
|
|
US6248127B1
(en)
|
1998-08-21 |
2001-06-19 |
Medtronic Ave, Inc. |
Thromboresistant coated medical device
|
|
DE19846008A1
(de)
|
1998-10-06 |
2000-04-13 |
Bayer Ag |
Phenylessigsäure-heterocyclylamide
|
|
KR20010080709A
(ko)
*
|
1998-12-10 |
2001-08-22 |
프리돌린 클라우스너, 롤란드 비. 보레르 |
프로콜라겐 ｃ-프로티나제 저해제
|
|
AU3118200A
(en)
*
|
1998-12-14 |
2000-07-03 |
Merck & Co., Inc. |
Hiv integrase inhibitors
|
|
WO2000035911A1
(en)
|
1998-12-16 |
2000-06-22 |
Aventis Pharma Limited |
Heteroaryl-cyclic acetals
|
|
AR035313A1
(es)
*
|
1999-01-27 |
2004-05-12 |
Wyeth Corp |
Inhibidores de tace acetilenicos de acido hidroxamico de sulfonamida a base de alfa-aminoacidos, composiciones farmaceuticas y el uso de los mismos para la manufactura de medicamentos.
|
|
US6258121B1
(en)
|
1999-07-02 |
2001-07-10 |
Scimed Life Systems, Inc. |
Stent coating
|
|
EA200601252A1
(ru)
*
|
1999-09-08 |
2006-10-27 |
Слоан-Кеттеринг Инститьют Фор Кэнсер Рисёч |
Новый класс веществ, вызывающих дифференцировку клеток и являющихся ингибиторами гистондеацетилазы, и способы их применения
|
|
US6203551B1
(en)
|
1999-10-04 |
2001-03-20 |
Advanced Cardiovascular Systems, Inc. |
Chamber for applying therapeutic substances to an implant device
|
|
KR20020070285A
(ko)
|
1999-11-23 |
2002-09-05 |
메틸진, 인크. |
히스톤 디아세틸라제의 억제제
|
|
US6251136B1
(en)
|
1999-12-08 |
2001-06-26 |
Advanced Cardiovascular Systems, Inc. |
Method of layering a three-coated stent using pharmacological and polymeric agents
|
|
US20030129724A1
(en)
|
2000-03-03 |
2003-07-10 |
Grozinger Christina M. |
Class II human histone deacetylases, and uses related thereto
|
|
EP1335898B1
(en)
|
2000-09-29 |
2005-11-23 |
TopoTarget UK Limited |
Carbamic acid compounds comprising an amide linkage as hdac inhibitors
|
|
GB0023983D0
(en)
|
2000-09-29 |
2000-11-15 |
Prolifix Ltd |
Therapeutic compounds
|
|
US6495719B2
(en)
|
2001-03-27 |
2002-12-17 |
Circagen Pharmaceutical |
Histone deacetylase inhibitors
|
|
AR035455A1
(es)
|
2001-04-23 |
2004-05-26 |
Hoffmann La Roche |
Derivados triciclicos de alquilhidroxamato , procesos para su elaboracion, composiciones farmaceuticas que los contienen, y el uso de dichos compuestos en la preparacion de medicamentos
|
|
WO2002089782A2
(en)
|
2001-05-09 |
2002-11-14 |
President And Fellows Of Harvard College |
Dioxanes and uses thereof
|
|
US7244853B2
(en)
|
2001-05-09 |
2007-07-17 |
President And Fellows Of Harvard College |
Dioxanes and uses thereof
|
|
US6897220B2
(en)
|
2001-09-14 |
2005-05-24 |
Methylgene, Inc. |
Inhibitors of histone deacetylase
|
|
US6517889B1
(en)
|
2001-11-26 |
2003-02-11 |
Swaminathan Jayaraman |
Process for coating a surface of a stent
|
|
WO2003075839A2
(en)
|
2002-03-04 |
2003-09-18 |
Aton Pharma, Inc. |
Methods of inducing terminal differentiation
|
|
US7148257B2
(en)
|
2002-03-04 |
2006-12-12 |
Merck Hdac Research, Llc |
Methods of treating mesothelioma with suberoylanilide hydroxamic acid
|
|
AU2003249682A1
(en)
|
2002-06-03 |
2003-12-19 |
Als Therapy Development Foundation |
Treatment of neurodegenerative diseases using proteasome modulators
|
|
TW200401638A
(en)
|
2002-06-20 |
2004-02-01 |
Bristol Myers Squibb Co |
Heterocyclic inhibitors of kinases
|
|
JP2006503082A
(ja)
|
2002-10-17 |
2006-01-26 |
メシルジーン、インコーポレイテッド |
ヒストンデアセチラーゼの阻害剤
|
|
ES2421516T3
(es)
|
2002-11-06 |
2013-09-03 |
Dana Farber Cancer Inst Inc |
Composiciones para tratar el cáncer usando el inhibidor de proteasomas PS-341
|
|
WO2004046104A2
(en)
|
2002-11-20 |
2004-06-03 |
Errant Gene Therapeutics, Llc |
Treatment of lung cells with histone deacetylase inhibitors
|
|
US7652036B2
(en)
|
2003-02-25 |
2010-01-26 |
Topotarget Uk Limited |
Carbamic acid compounds comprising a bicyclic heteroaryl group as HDAC inhibitors
|
|
PE20050206A1
(es)
|
2003-05-26 |
2005-03-26 |
Schering Ag |
Composicion farmaceutica que contiene un inhibidor de histona deacetilasa
|
|
EP1644323B1
(en)
|
2003-07-07 |
2015-03-18 |
Georgetown University |
Histone deacetylase inhibitors and methods of use thereof
|
|
WO2005012247A1
(en)
|
2003-07-30 |
2005-02-10 |
Hôpital Sainte-Justine |
Compounds and methods for the rapid quantitative analysis of proteins and polypeptides
|
|
KR100924737B1
(ko)
|
2003-08-26 |
2009-11-04 |
슬로안-케테링인스티튜트퍼캔서리서치 |
Ｈｄａｃ 억제제를 이용한 암의 치료 방법
|
|
US20050137234A1
(en)
|
2003-12-19 |
2005-06-23 |
Syrrx, Inc. |
Histone deacetylase inhibitors
|
|
JP4989976B2
(ja)
*
|
2004-02-13 |
2012-08-01 |
プレジデント アンド フェロウズ オブ ハーバード カレッジ |
翻訳開始阻害剤としての３−３−二置換オキシインドール
|
|
US20060008541A1
(en)
|
2004-07-08 |
2006-01-12 |
Bizmedic Co., Ltd. |
Sodium channel agonist
|
|
MX2007006523A
(es)
|
2004-12-03 |
2007-09-11 |
Nereus Pharmaceuticals Inc |
Metodos para utilizar compuestos heterociclicos [3.2.0] y sus analogos.
|
|
EP1830838B1
(en)
|
2004-12-03 |
2012-10-03 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for treating neoplastic diseases
|
|
CN101495116A
(zh)
|
2005-03-22 |
2009-07-29 |
哈佛大学校长及研究员协会 |
蛋白降解病症的治疗
|
|
AU2007214458C1
(en)
*
|
2006-02-14 |
2012-12-06 |
Dana-Farber Cancer Institute, Inc. |
Histone deacetylase inhibitors
|
|
AU2007345292B2
(en)
|
2006-02-14 |
2013-10-31 |
Dana-Farber Cancer Institute, Inc. |
Bifunctional histone deacetylase inhibitors
|
|
CA2654540C
(en)
|
2006-05-03 |
2017-01-17 |
President And Fellows Of Harvard College |
Histone deacetylase and tubulin deacetylase inhibitors
|
|
US8088951B2
(en)
|
2006-11-30 |
2012-01-03 |
Massachusetts Institute Of Technology |
Epigenetic mechanisms re-establish access to long-term memory after neuronal loss
|